TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33396626

Group type: EXPERIMENTAL
Intervention: Refined low amylose wheat (LAW‐R) bread
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Refined high amylose wheat (HAW‐R) bread
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Refined high amylose wheat (HAW‐R) bread (measured in ileorectostomised rats)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Conventional wheat breads
Number of subjects: 6
Study: 33502416

Group type: EXPERIMENTAL
Intervention: Plantago major supplementation (n = 35)
Number of subjects: 72
Study: 35171260

Group type: EXPERIMENTAL
Intervention: Robot-assisted radical cystectomy (RARC)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Open radical cystectomy (ORC)
Number of subjects: 302
Study: 34310672

Group type: EXPERIMENTAL
Intervention: Randomized self-organizing map algorithm
Number of subjects: 0
Study: 32726552

Group type: EXPERIMENTAL
Intervention: 10% lactic acid applied to one cheek
Number of subjects: 0

Group type: COMPARATOR
Intervention: Water applied to the contralateral cheek as control
Number of subjects: 0
Study: 34788812

Group type: EXPERIMENTAL
Intervention: Vedolizumab
Number of subjects: 0
Study: 32325176

Group type: EXPERIMENTAL
Intervention: Type O veneer
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Type OF veneer
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Type POF veneer
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Type POFP veneer
Number of subjects: 40

Group type: COMPARATOR
Intervention: Full crown
Number of subjects: 40
Study: 35285487

Group type: EXPERIMENTAL
Intervention: Adjuvant osimertinib for 3 years
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant osimertinib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant osimertinib with 50% discount
Number of subjects: 0
Study: 33221229

Group type: EXPERIMENTAL
Intervention: FBBG
Number of subjects: 25

Group type: COMPARATOR
Intervention: HED
Number of subjects: 25
Study: 32841271

Group type: EXPERIMENTAL
Intervention: Normal Weight Obesity (NWO)
Number of subjects: 1147

Group type: COMPARATOR
Intervention: Overtly Obese (OB)
Number of subjects: 1147

Group type: COMPARATOR
Intervention: Non-Obese (NO)
Number of subjects: 1147
Study: 34387797

Group type: EXPERIMENTAL
Intervention: Spiritual care intervention
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (no spiritual care)
Number of subjects: 71
Study: 34520092

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy - Long (CBT-L)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy - Brief (CBT-B)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Wait-List (WL)
Number of subjects: 100
Study: 32652064

Group type: EXPERIMENTAL
Intervention: Enhanced recovery after surgery protocol
Number of subjects: 168

Group type: COMPARATOR
Intervention: Standard perioperative care
Number of subjects: 168
Study: 35193718

Group type: EXPERIMENTAL
Intervention: Brazil and cashew nuts group (BN-Group): energy-restricted diet containing daily 45 g of nuts (15 g of Brazil nuts + 30 g of cashew nuts)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Brazil and cashew nuts group (BN-Group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group: energy-restricted diet without nuts
Number of subjects: 40
Study: 34775184

Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT) - any use
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Nicotine gum and nicotine patch used together
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Nicotine patch alone
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Nicotine gum alone
Number of subjects: 77
Study: 33992980

Group type: EXPERIMENTAL
Intervention: Radiomics model
Number of subjects: 149

Group type: COMPARATOR
Intervention: Conventional model
Number of subjects: 149
Study: 32634052

Group type: EXPERIMENTAL
Intervention: Group motivational interviewing
Number of subjects: 656

Group type: COMPARATOR
Intervention: Very brief advice
Number of subjects: 656
Study: 33470067

Group type: EXPERIMENTAL
Intervention: Pelvic lymphadenectomy alone
Number of subjects: 64

Group type: COMPARATOR
Intervention: Pelvic and para-aortic lymphadenectomy
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Omission of lymphadenectomy based on LNM scoring system
Number of subjects: 64
Study: 32346896

Group type: EXPERIMENTAL
Intervention: VR cognitive stimulation activity
Number of subjects: 236

Group type: COMPARATOR
Intervention: paper-and-pencil activity
Number of subjects: 236
Study: 34664616

Group type: EXPERIMENTAL
Intervention: Sinovac‐CoronaVac vaccine (2 doses, 28-day interval)
Number of subjects: 53
Study: 32044750

Group type: EXPERIMENTAL
Intervention: Knowledge Translation (KT) intervention including weekly email alerts and social media engagement for 12 weeks
Number of subjects: 510

Group type: COMPARATOR
Intervention: Self-serve control group with access to the Portal without targeted KT strategies
Number of subjects: 510
Study: 34325532

Group type: EXPERIMENTAL
Intervention: True electroacupuncture
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham electroacupuncture
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 50
Study: 32154613

Group type: EXPERIMENTAL
Intervention: Atorvastatin (ATV) 10 mg
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Atorvastatin (ATV) 20 mg
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Atorvastatin (ATV) 30 mg
Number of subjects: 402

Group type: COMPARATOR
Intervention: Control group (no atorvastatin)
Number of subjects: 402
Study: 34881440

Group type: EXPERIMENTAL
Intervention: Bolus Gastric Feeding (BGF)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Continuous Gastric Feeding (CGF)
Number of subjects: 147
Study: 35328854

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) engagement
Number of subjects: 1030

Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 1030

Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 1030
Study: 32609274

Group type: EXPERIMENTAL
Intervention: Individual selection of high-yielding passion fruit genotypes resistant to the Cowpea aphid-borne mosaic virus
Number of subjects: 5
Study: 36141439

Group type: EXPERIMENTAL
Intervention: Augmented reality appliance (AR)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Manual (freehand) technique (MN)
Number of subjects: 60
Study: 32049934

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting lung metastasis
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Higher risk of lung metastasis group
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Independent factors influencing lung metastasis
Number of subjects: 580
Study: 33941564

Group type: EXPERIMENTAL
Intervention: Siemens Atellica B.R.A.H.M.S PCT assay
Number of subjects: 45

Group type: COMPARATOR
Intervention: Abbott Architect B.R.A.H.M.S PCT assay
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both assays at clinically diagnostic cutoffs (0.1, 0.25, 0.5, 2.0 ng/mL)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Bland-Altman analysis
Number of subjects: 45
Study: 616388522

Group type: EXPERIMENTAL
Intervention: BRIGHT light exposure
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: BLUE light exposure
Number of subjects: 72

Group type: COMPARATOR
Intervention: CONTROL light exposure
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Exposure to melanopic light
Number of subjects: 72
Study: 35788169

Group type: EXPERIMENTAL
Intervention: Ivermectin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34370009

Group type: EXPERIMENTAL
Intervention: Patient-Reported Outcome Measurements (PROMS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standardized algorithms for analyzing PROMS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Integration of PROMS into cardiovascular interventions
Number of subjects: 0
Study: 35282955

Group type: EXPERIMENTAL
Intervention: 12-month behavioral intervention using nudges and feedback to promote healthier choices, building on existing cafeteria traffic light labels.
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: 12-month behavioral intervention for participants with lower health literacy.
Number of subjects: 510

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Behavioral intervention overall.
Number of subjects: 510
Study: 34164360

Group type: EXPERIMENTAL
Intervention: Bovine lactoferrin (bLf) 100 mg twice a day orally during antibiotic therapy
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study: 34390076

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention adapted for social anxiety disorder (MBI-SAD)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Cognitive behaviour group therapy (CBGT)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Treatment matching (preference for MBI-SAD or CBGT)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Perception of treatment credibility
Number of subjects: 97
Study: 34611208

Group type: COMPARATOR
Intervention: Pulsatile-release caffeine (160 mg)
Number of subjects: 22
Study: 32830436

Group type: EXPERIMENTAL
Intervention: Osteophyte resection (OR group)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Nonresection (NR group)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Both groups (OR and NR)
Number of subjects: 41
Study: 34477880

Group type: EXPERIMENTAL
Intervention: Genetically increased leukocyte telomere length (LTL)
Number of subjects: 12488

Group type: EXPERIMENTAL
Intervention: LTL associations at specific loci (3q26.2, 5p15.33, 10q24.33, 20q13.3)
Number of subjects: 12488

Group type: EXPERIMENTAL
Intervention: Genetic variation involving PARP1, PRRC2A, CARMIL1, POT1, and ATM‐NPAT1
Number of subjects: 12488
Study: 34702260

Group type: EXPERIMENTAL
Intervention: Submucosal approach
Number of subjects: 266

Group type: COMPARATOR
Intervention: Subserosal approach
Number of subjects: 266
Study: 34343632

Group type: EXPERIMENTAL
Intervention: Functional Training (FT)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Concurrent Training (CT)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 108
Study: 32160205

Group type: EXPERIMENTAL
Intervention: Intensive management (behavioral intensification to measure BP at home by texting, direct telephone call, or breakthrough visit)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 60
Study: 36394764

Group type: EXPERIMENTAL
Intervention: Study group (patients who developed pneumothorax)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (patients who did not develop pneumothorax)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 240
Study: 35997592

Group type: EXPERIMENTAL
Intervention: Twice-daily emollient application for the first 8 weeks of life
Number of subjects: 321

Group type: COMPARATOR
Intervention: Standard routine skin care
Number of subjects: 321
Study: 33517032

Group type: EXPERIMENTAL
Intervention: Combined anodal tDCS and gait training with FES (tDCS+FES, n=11)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Anodal tDCS with gait training (tDCS, n=11)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Combined sham tDCS and gait training with FES (FES, n=12)
Number of subjects: 34
Study: 34056781

Group type: EXPERIMENTAL
Intervention: Active TENS (Quell®), N = 62, used for three months
Number of subjects: 119

Group type: COMPARATOR
Intervention: Sham TENS, N = 57, used for three months
Number of subjects: 119
Study: 34324836

Group type: EXPERIMENTAL
Intervention: Aerosolised Ad5-nCoV high dose (HDmu group) - 2 × 10^10 viral particles
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Aerosolised Ad5-nCoV low dose (LDmu group) - 1 × 10^10 viral particles
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Mixed vaccination (MIX group) - Initial intramuscular (5 × 10^10 viral particles) followed by aerosolised booster (2 × 10^10 viral particles)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Intramuscular vaccination (1Dim group) - 5 × 10^10 viral particles
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Intramuscular vaccination (2Dim group) - 10 × 10^10 viral particles
Number of subjects: 130
Study: 35467557

Group type: EXPERIMENTAL
Intervention: Cold Forceps Polypectomy (CFP)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Cold Snare Polypectomy (CSP)
Number of subjects: 179
Study: 33811762

Group type: EXPERIMENTAL
Intervention: TradAC/RC
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: TradAC/XP
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: UltraAC/XP
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: TradAC/XP and UltraAC/XP
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: UltraAC/RC
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: UltraAC groups
Number of subjects: 40

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 40
Study: 33336222

Group type: COMPARATOR
Intervention: Withholding wellness education
Number of subjects: 272

Group type: COMPARATOR
Intervention: Withholding yoga
Number of subjects: 272
Study: 32304734

Group type: EXPERIMENTAL
Intervention: Cetirizine
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 35172792

Group type: EXPERIMENTAL
Intervention: High-translucent zirconia (Zr)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Zirconium lithium silicate (ZLS)
Number of subjects: 56
Study: 34749710

Group type: EXPERIMENTAL
Intervention: Individual-based PA challenge
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Friend-based PA challenge
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Team-based PA challenge
Number of subjects: 70

Group type: COMPARATOR
Intervention: General mood states
Number of subjects: 70
Study: 33140384

Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation during atrial fibrillation (AF group; n = 48)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Cryoballoon ablation during sinus rhythm (SR group; n = 147)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation during AF (AF group)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Cryoballoon ablation during SR (SR group)
Number of subjects: 195
Study: 34449790

Group type: EXPERIMENTAL
Intervention: H. pylori seropositivity
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: HIV seropositivity
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: Age in HIV negative individuals
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: H. pylori (multivariable analysis)
Number of subjects: 597
Study: 32571454

Group type: EXPERIMENTAL
Intervention: Early continuous blood purification (CBP)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 58
Study: 35679810

Group type: EXPERIMENTAL
Intervention: Euhydration + Treatment (ET)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dehydration + Treatment (DT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Dehydration + Control (DC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Euhydration + Control (EC)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Water supplementation
Number of subjects: 20
Study: 32573729

Group type: EXPERIMENTAL
Intervention: Decision tree analysis based on hemogram (white blood cell, hemoglobin, and platelet)
Number of subjects: 40395
Study: 35642163

Group type: EXPERIMENTAL
Intervention: Algorithm segmentation based on watershed and regional growth algorithm
Number of subjects: 152

Group type: COMPARATOR
Intervention: Manual segmentation (gold standard)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Tada formula (traditional)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Accurate Tada formula (based on 3D-Slicer)
Number of subjects: 152
Study: 33975745

Group type: EXPERIMENTAL
Intervention: Visual Abstracts (VAs)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Plain-text tweets
Number of subjects: 20
Study: 33216026

Group type: EXPERIMENTAL
Intervention: SOUL-P intervention (15 intensive sessions over 6 months and 6 maintenance sessions over 6 months)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: SOUL-P intervention
Number of subjects: 218

Group type: COMPARATOR
Intervention: Control group (similar number of sessions by community nurses)
Number of subjects: 218
Study: 32191943

Group type: EXPERIMENTAL
Intervention: Graphical risk estimate
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Verbal risk estimate
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: GRMT interest
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: GRMT impact on decision-making
Number of subjects: 30
Study: 36317082

Group type: EXPERIMENTAL
Intervention: AAT + CAT
Number of subjects: 92

Group type: COMPARATOR
Intervention: CAT
Number of subjects: 92
Study: 33579327

Group type: EXPERIMENTAL
Intervention: PDD-assisted en bloc transurethral resection (PDD-EBTUR)
Number of subjects: 160

Group type: COMPARATOR
Intervention: PDD-assisted conventional transurethral resection (PDD-cTURBT)
Number of subjects: 160
Study: 35587417

Group type: EXPERIMENTAL
Intervention: unsystematic variability
Number of subjects: 3

Group type: COMPARATOR
Intervention: systematic variability
Number of subjects: 3

Group type: COMPARATOR
Intervention: no variability (still image)
Number of subjects: 3
Study: 33691280

Group type: EXPERIMENTAL
Intervention: Flexible orthoses (reduced arch thickness)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Footwear only
Number of subjects: 23

Group type: COMPARATOR
Intervention: Standard orthoses
Number of subjects: 23
Study: 33569574

Group type: EXPERIMENTAL
Intervention: Intensive anti-hypertensive therapy
Number of subjects: 1881

Group type: COMPARATOR
Intervention: Standard anti-hypertensive therapy
Number of subjects: 1881
Study: 32074335

Group type: EXPERIMENTAL
Intervention: Calmare Scrambler Therapy (ST)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 47
Study: 34958174

Group type: EXPERIMENTAL
Intervention: VX-128 (300 mg single dose)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: VX-128 (100 mg once daily for up to 10 days)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: VX-128 (multiple doses)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: VX-128 (10 mg once daily)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: VX-128 (10 and 30 mg once daily)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 32818475

Group type: EXPERIMENTAL
Intervention: Multimodal physical therapy
Number of subjects: 212

Group type: COMPARATOR
Intervention: Topical lidocaine (5% ointment)
Number of subjects: 212
Study: 36184997

Group type: EXPERIMENTAL
Intervention: CyberKnife hypofractionated radiotherapy (25 Gy delivered in five fractions)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Conventional fractionated radiotherapy (up to 36 Gy)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: CyberKnife hypofractionated radiotherapy
Number of subjects: 74

Group type: COMPARATOR
Intervention: Conventional fractionated radiotherapy
Number of subjects: 74
Study: 34222273

Group type: EXPERIMENTAL
Intervention: Assigned treatments that match patient expectations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Assigned treatments that do not match patient expectations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomisation process
Number of subjects: 0
Study: 35365509

Group type: EXPERIMENTAL
Intervention: Fluorescence Guided Bowel Anastomosis
Number of subjects: 978

Group type: COMPARATOR
Intervention: Conventional Bowel Anastomosis
Number of subjects: 978
Study: 32259297

Group type: EXPERIMENTAL
Intervention: Laparoscopic distal pancreatectomy (LDP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open distal pancreatectomy (ODP)
Number of subjects: 60
Study: 34727185

Group type: EXPERIMENTAL
Intervention: One night of sleep deprivation
Number of subjects: 42

Group type: COMPARATOR
Intervention: 9 hours of sleep
Number of subjects: 42
Study: 33846506

Group type: EXPERIMENTAL
Intervention: Cascade convolutional neural net (CNN) for automated cephalometric analysis
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Orthodontist's manual measurement
Number of subjects: 1000

Group type: COMPARATOR
Intervention: ROI detection using RetinaNet
Number of subjects: 1000
Study: 34837524

Group type: EXPERIMENTAL
Intervention: Flaxseed (30 g/day) plus regular diet (RF group)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Flaxseed (30 g/day) plus anti-inflammatory diet (AIF group)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Roasted wheat (30 g/day) plus regular diet (RW group)
Number of subjects: 120
Study: 34737472

Group type: EXPERIMENTAL
Intervention: Peer-referral and clinic welcome programme
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Peer-referral and clinic welcome programme with training in youth-friendly service provision
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group (56 clinics)
Number of subjects: 116
Study: 35014958

Group type: EXPERIMENTAL
Intervention: Fitbit Flex and automated SMS text messages
Number of subjects: 44

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 44
Study: 32420349

Group type: EXPERIMENTAL
Intervention: Vaginal gel based on carboxy‐methyl‐beta‐glucan (1 application/day for 20 days per month for 3 months)
Number of subjects: 784

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 784
Study: 35222072

Group type: EXPERIMENTAL
Intervention: High-intensity Inspiratory Muscle Training (IMT)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Sham low-intensity Inspiratory Muscle Training (IMT)
Number of subjects: 41
Study: 34080237

Group type: EXPERIMENTAL
Intervention: 500 mg curcuminoids daily for 7 days
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 35981633

Group type: EXPERIMENTAL
Intervention: FDA bioequivalence approach
Number of subjects: 36

Group type: COMPARATOR
Intervention: EMA bioequivalence approach
Number of subjects: 36
Study: 33759909

Group type: EXPERIMENTAL
Intervention: Colonoscopic polypectomy without discontinuation of antithrombotic medication
Number of subjects: 94

Group type: COMPARATOR
Intervention: Colonoscopic polypectomy after discontinuation of antithrombotic medication
Number of subjects: 94
Study: 32702245

Group type: EXPERIMENTAL
Intervention: Galcanezumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fremanezumab
Number of subjects: 0
Study: 35383074

Group type: EXPERIMENTAL
Intervention: Family presence during CPR (n=160)
Number of subjects: 1085

Group type: COMPARATOR
Intervention: Control group (n=158)
Number of subjects: 1085